Regentis Biomaterials Ltd (NASDAQ:RGNT) IPO will take place September, 11 on the NASDAQ exchange under the ticker RGNT.
The company is offering shares at an expected price between $10.00 and $12.00 per share with an insider lock-up period of 180 days ending on March 10, 2026.
See also: Benzinga IPO Calendar
About Regentis Biomaterials Ltd
Regentis Biomaterials Ltd. is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore the health and enhance quality of life of patients.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
